Ketazolam treatment for spasticity: double-blind study of a new drug.

A minor tranquilizer, ketazolam, was tested in a double-blind, randomized, crossover study of 50 patients for its effects in neurologic spasticity. The drug was compared with diazepam (widely accepted as an effective antispasticity agent) and a placebo. The patients with spasticity were almost all cases of multiple sclerosis (24) or stroke (24). Thirty-nine patients completed the study. There was not statistically significant superiority of either diazepam or ketazolam, but both relieved symptoms significantly better than the placebo, as measured clinically and by electromyographic recording of deep tendon reflexes. Ketazolam is a relatively safe and clinically effective antispasticity agent (especially for patients with multiple sclerosis). The well-known "big 3"--dantrolene sodium, baclofen, and diazepam--produce large and small problems in many individual cases; hence, ketazolam now offers a safe and clinically useful alternative.
AuthorsJ V Basmajian, K Shankardass, D Russell, V Yucel
JournalArchives of physical medicine and rehabilitation (Arch Phys Med Rehabil) Vol. 65 Issue 11 Pg. 698-701 (Nov 1984) ISSN: 0003-9993 [Print] UNITED STATES
PMID6149738 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Anxiety Agents
  • Benzodiazepinones
  • Capsules
  • Benzodiazepines
  • ketazolam
  • Adolescent
  • Adult
  • Aged
  • Anti-Anxiety Agents (adverse effects, therapeutic use)
  • Benzodiazepines
  • Benzodiazepinones (adverse effects, therapeutic use)
  • Capsules
  • Cerebrovascular Disorders (physiopathology)
  • Clinical Trials as Topic
  • Craniocerebral Trauma (physiopathology)
  • Double-Blind Method
  • Electromyography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis (physiopathology)
  • Muscle Spasticity (drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password:
Type Validation Code Shown: